Metraipolis › archive › dc_520bea2a2010

Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study — Europe PMC PMID:42795441

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42795441
DOI: 10.3390/life16091576
License (as archived): solo-consultazione
Archived: 2026-10-08T00:32:09.954Z
SHA-256 of the archived text: d4bc0e50c3fec66d31fd273a1e144e76a5e7d2766abd549782196f188df305e8
Stable URL of this page: https://metraipolis.com/documento/dc_520bea2a2010

How to cite

Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study — Europe PMC PMID:42795441 — Europe PMC (en), https://europepmc.org/article/MED/42795441 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_520bea2a2010 (Metraipolis archive dc_520bea2a2010, sha256 d4bc0e50c3fec66d31fd273a1e144e76a5e7d2766abd549782196f188df305e8)

BibTeX

@misc{dc520bea2a2010,
  title = {Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study — Europe PMC PMID:42795441},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795441},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_520bea2a2010; sha256 d4bc0e50c3fec66d31fd273a1e144e76a5e7d2766abd549782196f188df305e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795441. Agents can read the archived copy with the MCP tool read_document.